These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 2985865)

  • 1. [Prevention of cholelithiasis].
    Mansurov KhKh
    Klin Med (Mosk); 1985 Jan; 63(1):10-6. PubMed ID: 2985865
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative evaluation of chenodeoxycholic and ursodeoxycholic acids in obese patients. Effects on biliary lipid metabolism during weight maintenance and weight reduction.
    Mazzella G; Bazzoli F; Festi D; Ronchi M; Aldini R; Roda A; Grigolo B; Simoni P; Villanova N; Roda E
    Gastroenterology; 1991 Aug; 101(2):490-6. PubMed ID: 2065925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparative study of bile sedimentation rate and pH normally and in cholelithiasis patients].
    Mansurov KhKh; Dzhuraev KhSh; Mansurova FKh
    Ter Arkh; 1987; 59(5):87-91. PubMed ID: 3616951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biliary lipid metabolism in gallstone disease and during gallstone dissolution treatment.
    Nilsell K
    Acta Chir Scand Suppl; 1985; 528():1-38. PubMed ID: 3866449
    [No Abstract]   [Full Text] [Related]  

  • 5. [The dissolving of cholesterol gallstones. A current therapeutic problem].
    Erb W
    Med Klin; 1975 Jul; 70(28-29):1199-1207. PubMed ID: 1101004
    [No Abstract]   [Full Text] [Related]  

  • 6. [Main achievements in the study of the pathogenesis and treatment of cholelithiasis].
    Mansurov KhKh
    Ter Arkh; 1982; 54(12):27-31. PubMed ID: 6297110
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of litholytic bile acids on cholesterol absorption in gallstone patients.
    LaRusso NF; Thistle JL
    Gastroenterology; 1983 Feb; 84(2):265-71. PubMed ID: 6848406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [New therapeutic methods--technics, application, efficacy and problems. Litholysis. a) Theory of litholysis and development of litholytic agents].
    Makino I; Yoneda M; Tamasawa N; Takebe K
    Nihon Rinsho; 1987 Jul; 45(7):1539-46. PubMed ID: 3669350
    [No Abstract]   [Full Text] [Related]  

  • 9. [Comparison of the effects of an equal dose of 15 mg/kg/day of chenodeoxycholic and ursodeoxycholic acid on the composition of biliary lipids and acids in the bile in radiotransparent biliary lithiasis].
    Garrido G; Breto M; Alegre B; Pérez Aguilar F; Berenguer J
    Rev Esp Enferm Apar Dig; 1983 Oct; 64(4):261-9. PubMed ID: 6658120
    [No Abstract]   [Full Text] [Related]  

  • 10. Gallstone formation and dissolution.
    Morrissey KP
    Major Probl Clin Surg; 1982; 16():61-100. PubMed ID: 7054618
    [No Abstract]   [Full Text] [Related]  

  • 11. Bile acids in health and disease.
    Bouchier IA
    Lancet; 1987 Nov; 2(8568):1140-2. PubMed ID: 2890032
    [No Abstract]   [Full Text] [Related]  

  • 12. [Therapy of cholelithiasis].
    Sauerbruch T; Paumgartner G
    Internist (Berl); 1986 Oct; 27(10):643-55. PubMed ID: 3539856
    [No Abstract]   [Full Text] [Related]  

  • 13. Bile acids, cholesterol, gallstone calcification, and the enterohepatic circulation of bilirubin.
    Hofmann AF
    Gastroenterology; 1999 May; 116(5):1276-7. PubMed ID: 10220530
    [No Abstract]   [Full Text] [Related]  

  • 14. Ursodeoxycholic acid versus chenodeoxycholic acid. Comparison of their effects on bile acid and bile lipid composition in patients with cholesterol gallstones.
    Stiehl A; Czygan P; Kommerell B; Weis HJ; Holtermüller KH
    Gastroenterology; 1978 Dec; 75(6):1016-20. PubMed ID: 30674
    [No Abstract]   [Full Text] [Related]  

  • 15. Highlights of the meeting on prevention of gallstones.
    Grundy SM; Kalser SC
    Hepatology; 1987; 7(5):946-51. PubMed ID: 3308668
    [No Abstract]   [Full Text] [Related]  

  • 16. Mechanism of cholesterol gallstones formation.
    Grundy SM
    Semin Liver Dis; 1983 May; 3(2):97-111. PubMed ID: 6683429
    [No Abstract]   [Full Text] [Related]  

  • 17. Changes of bile acid and lipid composition in blood and bile in the clinical course after the initiation of cheno- and ursodeoxycholic acid therapy in patients with cholesterol gallstones.
    Iwamura K
    Tokai J Exp Clin Med; 1982 Nov; 7(6):671-83. PubMed ID: 7184199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of beta-sitosterol alone or in combination with chenic acid on cholesterol saturation of bile and cholesterol absorption in gallstone patients.
    Tangedahl TN; Thistle JL; Hofmann AF; Matseshe JW
    Gastroenterology; 1979 Jun; 76(6):1341-6. PubMed ID: 437431
    [No Abstract]   [Full Text] [Related]  

  • 19. Changes in serum bile acids during treatment with chenodiol or ursodiol for dissolution of cholesterol gallstones.
    Nowak M; Panveliwalla D; Pertsemlidis D
    Mt Sinai J Med; 1983; 50(3):240-4. PubMed ID: 6604868
    [No Abstract]   [Full Text] [Related]  

  • 20. Cheno and urso compared and contrasted.
    Dowling RH
    Acta Med Port; 1983 Jan; 4(1):51-62. PubMed ID: 6337454
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.